INtraoperative photoDYnamic Therapy of GliOblastoma

NACompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

May 5, 2017

Primary Completion Date

April 28, 2021

Study Completion Date

April 28, 2021

Conditions
Glioblastoma
Interventions
DEVICE

"perPDT"

"The protocol requires the realization of specific procedures in addition to the usual care.~The per-operative photodynamic therapy (perPDT) added to surgery for glioblastoma excision. The patient will receive 5-ALA (5- alanine ,GLIOLAN drinkable) 4h before surgery + lighting of the tumor bed by a light source (laser) at the end of resection (Prolonged surgery of 45 minutes)."

DRUG

GLIOLAN

patient will receive 5-ALA (5- alanine ,GLIOLAN drinkable) 4h before surgery

Trial Locations (1)

Unknown

Hôpital Roger Salengro, CHRU, Lille

All Listed Sponsors
collaborator

Institut National de la Santé Et de la Recherche Médicale, France

OTHER_GOV

lead

University Hospital, Lille

OTHER

NCT03048240 - INtraoperative photoDYnamic Therapy of GliOblastoma | Biotech Hunter | Biotech Hunter